At the inter-tumor level, according to previous observations on glioblastoma (42, 61, 63), our analysis shows that all patient-derived cell lines analyzed express the neural cell adhesion molecule CD56, the integrin β1 CD29 and its activator CD63, even if a great variability between each patient-derived cell line was observed. This evidence concerns the gene NCAM1 and glioblastoma.